A carregar...
Bevacizumab Improves Quality of Life in Patients with Recurrent Glioblastoma
Objective. To quantify the benefits in survival and quality of life in patients receiving bevacizumab (BEV) for recurrent glioblastoma (GBM). Methods. This is a retrospective study of 40 adult patients with recurrent GBM treated between 2005 and 2009 at a single institution. All patients had initial...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3263615/ https://ncbi.nlm.nih.gov/pubmed/22312554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/602812 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|